Global and China Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 13-Oct-2020
No. of pages: 96
Inquire Before Buying

Global Companion Diagnostic Tests in Oncology Scope and Market Size

Companion Diagnostic Tests in Oncology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Tests in Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Protein Detection

- DNA Detection

Market segment by Application, split into

- Pharmaceutical & Biotechnology Companies

- Medical Device Companies

- Research Institutes

Based on regional and country-level analysis, the Companion Diagnostic Tests in Oncology market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Companion Diagnostic Tests in Oncology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- Abbott

- Roche

- Genomic Health

- QIAGEN

- Agilent

- Agendia

- BioMerieux

- Illumina

- Siemens Healthcare

- Thermo Fisher

Global and China Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Protein Detection
1.2.3 DNA Detection
1.3 Market by Application
1.3.1 Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2026
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Tests in Oncology Market Perspective (2015-2026)
2.2 Global Companion Diagnostic Tests in Oncology Growth Trends by Regions
2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Companion Diagnostic Tests in Oncology Historic Market Share by Regions (2015-2020)
2.2.3 Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Tests in Oncology Players by Market Size
3.1.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue (2015-2020)
3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2015-2020)
3.2 Global Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue
3.4 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio
3.4.1 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests in Oncology Revenue in 2019
3.5 Key Players Companion Diagnostic Tests in Oncology Area Served
3.6 Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Tests in Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Tests in Oncology Breakdown Data by Type (2015-2026)
4.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2015-2020)
4.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2021-2026)
5 Companion Diagnostic Tests in Oncology Breakdown Data by Application (2015-2026)
5.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Application (2015-2020)
5.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Companion Diagnostic Tests in Oncology Market Size (2015-2026)
6.2 North America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
6.3 North America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
6.4 North America Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Companion Diagnostic Tests in Oncology Market Size (2015-2026)
7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
7.4 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Companion Diagnostic Tests in Oncology Market Size (2015-2026)
8.2 China Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
8.3 China Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
8.4 China Companion Diagnostic Tests in Oncology Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Companion Diagnostic Tests in Oncology Market Size (2015-2026)
9.2 Japan Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
9.3 Japan Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
9.4 Japan Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Companion Diagnostic Tests in Oncology Market Size (2015-2026)
10.2 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
10.3 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
10.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Companion Diagnostic Tests in Oncology Introduction
11.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020))
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Companion Diagnostic Tests in Oncology Introduction
11.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.2.5 Roche Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Details
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Introduction
11.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.3.5 Genomic Health Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Introduction
11.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.4.5 QIAGEN Recent Development
11.5 Agilent
11.5.1 Agilent Company Details
11.5.2 Agilent Business Overview
11.5.3 Agilent Companion Diagnostic Tests in Oncology Introduction
11.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.5.5 Agilent Recent Development
11.6 Agendia
11.6.1 Agendia Company Details
11.6.2 Agendia Business Overview
11.6.3 Agendia Companion Diagnostic Tests in Oncology Introduction
11.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.6.5 Agendia Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Introduction
11.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.7.5 BioMerieux Recent Development
11.8 Illumina
11.8.1 Illumina Company Details
11.8.2 Illumina Business Overview
11.8.3 Illumina Companion Diagnostic Tests in Oncology Introduction
11.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.8.5 Illumina Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Details
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Introduction
11.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.9.5 Siemens Healthcare Recent Development
11.10 Thermo Fisher
11.10.1 Thermo Fisher Company Details
11.10.2 Thermo Fisher Business Overview
11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Introduction
11.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
11.10.5 Thermo Fisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Protein Detection
Table 4. Key Players of DNA Detection
Table 5. Global Companion Diagnostic Tests in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Companion Diagnostic Tests in Oncology Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Companion Diagnostic Tests in Oncology Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2015-2020)
Table 9. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2021-2026)
Table 11. Companion Diagnostic Tests in Oncology Market Market Trends
Table 12. Companion Diagnostic Tests in Oncology Market Drivers
Table 13. Companion Diagnostic Tests in Oncology Market Challenges
Table 14. Companion Diagnostic Tests in Oncology Market Restraints
Table 15. Global Companion Diagnostic Tests in Oncology Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Companion Diagnostic Tests in Oncology Market Share by Players (2015-2020)
Table 17. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2019)
Table 18. Global Companion Diagnostic Tests in Oncology by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Companion Diagnostic Tests in Oncology Market Size Share by Type (2015-2020)
Table 24. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2021-2026)
Table 25. Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2015-2020)
Table 26. Global Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2021-2026)
Table 28. North America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 30. North America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 32. North America Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020)
Table 34. Europe Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 36. Europe Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 38. Europe Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020)
Table 40. China Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 41. China Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 42. China Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 43. China Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 44. China Companion Diagnostic Tests in Oncology Market Size by Region (US$ Million) (2015-2020)
Table 45. China Companion Diagnostic Tests in Oncology Market Share by Region (2015-2020)
Table 46. Japan Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 48. Japan Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 50. Japan Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020)
Table 52. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020)
Table 54. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020)
Table 56. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020)
Table 58. Abbott Company Details
Table 59. Abbott Business Overview
Table 60. Abbott Product
Table 61. Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 62. Abbott Recent Development
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Product
Table 66. Roche Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 67. Roche Recent Development
Table 68. Genomic Health Company Details
Table 69. Genomic Health Business Overview
Table 70. Genomic Health Product
Table 71. Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 72. Genomic Health Recent Development
Table 73. QIAGEN Company Details
Table 74. QIAGEN Business Overview
Table 75. QIAGEN Product
Table 76. QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 77. QIAGEN Recent Development
Table 78. Agilent Company Details
Table 79. Agilent Business Overview
Table 80. Agilent Product
Table 81. Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 82. Agilent Recent Development
Table 83. Agendia Company Details
Table 84. Agendia Business Overview
Table 85. Agendia Product
Table 86. Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 87. Agendia Recent Development
Table 88. BioMerieux Company Details
Table 89. BioMerieux Business Overview
Table 90. BioMerieux Product
Table 91. BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 92. BioMerieux Recent Development
Table 93. Illumina Business Overview
Table 94. Illumina Product
Table 95. Illumina Company Details
Table 96. Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 97. Illumina Recent Development
Table 98. Siemens Healthcare Company Details
Table 99. Siemens Healthcare Business Overview
Table 100. Siemens Healthcare Product
Table 101. Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 102. Siemens Healthcare Recent Development
Table 103. Thermo Fisher Company Details
Table 104. Thermo Fisher Business Overview
Table 105. Thermo Fisher Product
Table 106. Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million)
Table 107. Thermo Fisher Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Tests in Oncology Market Share by Type: 2020 VS 2026
Figure 2. Protein Detection Features
Figure 3. DNA Detection Features
Figure 4. Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical & Biotechnology Companies Case Studies
Figure 6. Medical Device Companies Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Companion Diagnostic Tests in Oncology Report Years Considered
Figure 9. Global Companion Diagnostic Tests in Oncology Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Companion Diagnostic Tests in Oncology Market Share by Regions: 2020 VS 2026
Figure 11. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2021-2026)
Figure 12. Global Companion Diagnostic Tests in Oncology Market Share by Players in 2019
Figure 13. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests in Oncology Revenue in 2019
Figure 15. North America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Abbott Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 43. Roche Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 44. Genomic Health Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 45. QIAGEN Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 46. Agilent Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 47. Agendia Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 48. BioMerieux Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 49. Illumina Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 50. Siemens Healthcare Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 51. Thermo Fisher Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs